McKesson Co. (NYSE:MCK) CFO Britt J. Vitalone sold 22,085 shares of the company’s stock in a transaction that occurred on Monday, September 13th. The shares were sold at an average price of $203.75, for a total value of $4,499,818.75. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.
NYSE MCK traded up $2.74 on Wednesday, reaching $206.73. The stock had a trading volume of 13,624 shares, compared to its average volume of 1,073,468. The company has a debt-to-equity ratio of 82.70, a quick ratio of 0.53 and a current ratio of 0.99. McKesson Co. has a 12-month low of $141.32 and a 12-month high of $210.00. The business’s 50-day moving average price is $199.56 and its 200 day moving average price is $194.07. The stock has a market cap of $31.98 billion, a P/E ratio of -7.29, a price-to-earnings-growth ratio of 1.33 and a beta of 0.88.
McKesson (NYSE:MCK) last issued its quarterly earnings results on Wednesday, August 4th. The company reported $5.56 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $4.09 by $1.47. The firm had revenue of $62.67 billion during the quarter, compared to the consensus estimate of $60.16 billion. McKesson had a positive return on equity of 216.39% and a negative net margin of 1.83%. The company’s revenue for the quarter was up 12.6% on a year-over-year basis. During the same period last year, the company earned $2.77 earnings per share. On average, sell-side analysts predict that McKesson Co. will post 20.27 earnings per share for the current year.
Institutional investors and hedge funds have recently made changes to their positions in the business. Y Intercept Hong Kong Ltd lifted its holdings in shares of McKesson by 539.2% in the 1st quarter. Y Intercept Hong Kong Ltd now owns 11,301 shares of the company’s stock valued at $2,221,000 after buying an additional 9,533 shares during the period. Arrowstreet Capital Limited Partnership lifted its holdings in McKesson by 74.2% in the first quarter. Arrowstreet Capital Limited Partnership now owns 734,812 shares of the company’s stock valued at $143,318,000 after acquiring an additional 313,020 shares during the period. Advisor Group Holdings Inc. boosted its position in shares of McKesson by 4.3% during the 2nd quarter. Advisor Group Holdings Inc. now owns 32,584 shares of the company’s stock worth $6,239,000 after purchasing an additional 1,332 shares in the last quarter. Penserra Capital Management LLC grew its stake in shares of McKesson by 18.6% during the 1st quarter. Penserra Capital Management LLC now owns 408 shares of the company’s stock worth $79,000 after purchasing an additional 64 shares during the period. Finally, Todd Asset Management LLC increased its holdings in shares of McKesson by 6.1% in the 2nd quarter. Todd Asset Management LLC now owns 104,367 shares of the company’s stock valued at $19,959,000 after purchasing an additional 5,958 shares in the last quarter. 86.16% of the stock is currently owned by institutional investors.
MCK has been the subject of a number of research analyst reports. Credit Suisse Group upped their price target on McKesson from $222.00 to $224.00 and gave the company a “neutral” rating in a report on Monday, August 9th. Deutsche Bank Aktiengesellschaft upped their price target on McKesson from $237.00 to $261.00 and gave the company a “buy” rating in a report on Thursday, August 5th. Two research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Buy” and an average price target of $224.13.
McKesson Corp. engages in the provision of supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology. It operates through the following segments: U.S. Pharmaceutical; International; Medical-Surgical Solutions; and Prescription Technology Solutions (“RxTS“).
Recommended Story: Cash Asset Ratio
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.